Publicação:
Medicação de alto custo para portador de sofrimento psíquico: Um estudo preliminar dos custos

Imagem de Miniatura

Arquivos

2-s2.0-55049109893.pdf (92.84 KB)

Data

2007-01-01

Autores

Orientador

Coorientador

Pós-graduação

Curso de graduação

Título da Revista

ISSN da Revista

Título de Volume

Editor

Tipo

Artigo

Direito de acesso

Acesso abertoAcesso Aberto

Resumo

The present work aims to raise the costs of high-cost drugs used to treat patients of Refractory Schizophrenia in ambulatory unit. The study was carried out in the Psychosocial Support Center, which treated 33 patients with these medications, during the period of June, 2005 to May, 2006. Data analysis disclosed that the mostly used drugs to treat the carriers of Refractory Schizophrenia were: clozapina and risperidona. It was observed that the treatment with olanzapina is more expensive than that with risperidona. The study concluded that the analysis of the consumption and costs of drugs of high cost is necessary to subside better management of the expenses and new investments in the service. Moreover, the necessity of more studies in the area was also identified to contribute with the control of costs.

Descrição

Palavras-chave

Atypical antipsychotics, Costs, Schizophrenia, clozapine, neuroleptic agent, olanzapine, quetiapine, risperidone, ziprasidone, ambulatory care, clinical article, controlled study, cost control, cost effectiveness analysis, drug cost, drug use, human, mental health service, schizophrenia

Idioma

Português

Como citar

Acta Scientiarum - Health Sciences, v. 29, n. 1, p. 19-23, 2007.

URI

http://hdl.handle.net/11449/69491

Itens relacionados

Financiadores

Coleções

Botucatu - FMB - Faculdade de Medicina

Unidades

Departamentos

Cursos de graduação

Programas de pós-graduação